Therefore, we believed that combining two major functions (MAO-B inhibition and metal chelation) into a single molecule may afford a promising multifunctional therapeutic strategy for AD therapy (metal chelation, MAO-B inhibition, Aβ aggregation inhibition, and antioxidant activity). The gene discussed is MAOB; the disease is Alzheimer disease.